Liz Devlin: Supporting Safe Pregnancy in Women with HHT
Liz Devlin, Patient Coordinator at Mercy University Hospital, shared a post on LinkedIn:
”Pregnancy and HHT: Planning for the safest possible journey
For most women with Hereditary Haemorrhagic Telangiectasia (HHT), pregnancy is successful. However, because HHT can affect blood vessels in the lungs, brain and other organs, every pregnancy should be considered high risk and managed with appropriate specialist care.
Good planning before and during pregnancy can significantly reduce the risk of complications for both mother and baby.
Key areas of care include:
- Screening for arteriovenous malformations (AVMs) before pregnancy where appropriate.
- Monitoring and treating anaemia.
- Assessing oxygen levels and investigating new or worsening breathlessness.
- Planning the safest anaesthetic approach if required.
- Developing an individualised birth plan with the multidisciplinary team.
- Ensuring appropriate follow-up after delivery.
No two patients with HHT are the same.
A personalised care plan, developed in collaboration with HHT specialists, obstetricians, anaesthetists and other healthcare professionals, is essential to achieve the best possible outcomes.
Raising awareness of these recommendations helps ensure that people living with HHT receive the specialist care and support they need throughout pregnancy.
This post is intended for educational purposes only and should not replace individual medical advice.
Anyone with HHT who is planning a pregnancy or is currently pregnant should discuss their care with their specialist healthcare team.”
Stay updated with Hemostasis Today.
-
Jul 22, 2026, 18:31Clivaz Léa: Presenting Research on Pregnancy-Related Pulmonary Embolism at ISTH 2026
-
Jul 22, 2026, 18:18Mohammed Alo: Arteries And Veins Are Structurally Built For Different Jobs
-
Jul 22, 2026, 18:14Luke Blount: Reflecting on an Inspiring ISTH 2026 Congress
-
Jul 22, 2026, 17:50Karen Dorsett: A Quick Quiz That Could Change How You Think About Blood Clots
-
Jul 22, 2026, 16:46Congressman Don Davis: Working Toward a Better Future for Rare Disease Patients
-
Jul 22, 2026, 16:04Wolfgang Miesbach: How SUMOylation Limits AAV Gene Therapy
-
Jul 22, 2026, 15:27Obstetric APS: From Standardized Anticoagulation to Biology-Driven Precision Care
-
Jul 22, 2026, 14:31What Could Shape the Future of Hemophilia A Care? – Novo Nordisk Medical US
-
Jul 22, 2026, 10:35Ifeanyichukwu Ifechidere: We’ve Trained an Entire Generation of Clinicians to Fear The Wrong Thing About HIT